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The anticancer effect of β-2-himachalen-6-ol from 
Lebanese wild carrot on human acute myeloid leukemia 
cells 
Joelle C. Boulos 
ABSTRACT 
Almost all adult leukemia patients suffer from acute myeloid leukemia with around 
20,830 new cases and 10,460 deaths expected in the United States in 2015 due to poor 
prognosis. Daucus carota L. ssp. carota (Apiacea) is a medicinal plant used in folk 
medicine worldwide. In Lebanon, the plant has been used for the treatment of several 
ailments including cancer. Earlier studies in our lab revealed that Daucus carota oil extract 
(DCOE) composition varied significantly between Lebanon and European countries. Also, 
the oil extract and its fractions were shown to have strong antioxidant and anticancer 
activities. In the present work, GC-MS was used to study the composition of DCOE 
obtained from roots, stems, leaves and umbels which are collected from two different 
regions in Lebanon (North and Mount Lebanon). β-2-himachalen-6-ol, the major 
component of F2 fraction, was also assessed in opened and closed umbels and at three 
different altitudes. Daucus carota oil extract was subjected to silica gel column 
chromatography in order to isolate the major compound β-2-himachalen-6-ol and test its 
anticancer activity against five AML cell lines: Mono-Mac-1, HL60, KG1, ML2, and 
U937. Results revealed that the chemical composition of the Lebanese DCOE varied 
drastically among different plant parts and between different locations. In addition, β-2-
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himachalen-6-ol seems to be only present in the Lebanese wild carrot, and it is prevalent 
in closed umbels collected from Mount Lebanon without significant changes with altitude. 
All AML cells were sensitive to the major compound with Mono-Mac-1 being the most 
sensitive (12 µg/mL), and U937 the least sensitive (30 µg/mL). Cell cycle analysis using 
flow cytometry revealed an increase in the sub-G1 population. Analysis of cell death after 
treatment with various drug concentrations showed that cells were positive for annexin V, 
PI, and active caspase staining, indicating a caspase dependent apoptotic cell death. There 
was no sign of cell cycle arrest. Co-incubation of AML cells with β-2-himachalen-6-ol 
and a MEK1/2 inhibitor (U0126) revealed an additive effect in Mono-Mac-1 and U937; 
the effect was mild in HL60. In conclusion, Daucus carota chemical composition varies 
drastically among different locations in Lebanon with β-2-himachalen-6-ol being present 
mainly in the mature closed umbel. β-2-himachalen-6-ol possesses potent anticancer 
activity against a panel of AML cells, an effect that may be mediated via a suppression of 
the MAPK/Erk and PI3K/Akt pathways. 
Keywords: Daucus carota, β-2-himachalen-6-ol, Cancer, Acute myeloid leukemia, 
Apoptosis, MAPK/Erk and PI3K/Akt pathways 
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CHAPTER 1 
 INTRODUCTION 
1.1 Introduction 
Phytotherapy relies on medicinal plants to treat several diseases. As stated by the 
World Health Organization more than 80% of the world’s population relies on folk 
medicine (Parveen & Sharma, 2014) where around 40000 to 70000 tracheophytes are 
used in phytomedicine (McChesney, Venkataraman, & Henri, 2007). In order to 
improve the efficiency of phytomedicine, investigations of medicinal plants used in 
folk medicine necessitate the study of the chemical composition of the plant extract, 
pharmacological properties of the isolated major compounds, and inherent information 
of folk curers (Ross, 2007; Soejarto, 2005). The mechanism of action of natural 
products is under examination due to the progression in chemistry, biotechnology, and 
molecular biology. Thus, natural antibacterial, antiparasitic, antidiabetic, as well as 
anticancer drugs are gaining great research importance in pharmaceutical companies 
(Newman & Cragg, 2012). 
Cancer, for instance, turned out to be one of the most contentious diseases; in fact, 
1,658,370 new cancer cases and 589,430 cancer deaths are estimated to occur in the 
United States in 2015 (Siegel, Miller, & Jemal, 2015). Due to the increased universal 
mortality rate and the absence of remedies, oncology has become the main concern of 
research. Race, gender, age, genetic character, inadequate diet and hazard 
environmental carcinogen are various lifestyles or risk factors involved in causing 
cancer (Chang & Kinghorn, 2001; Reddy, Odhav, & Bhoola, 2003; Wallace, Martin, 
& Ambs, 2011). Cancer, known as malignant tumor, is characterized by an abnormal 
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cell growth and the potential to invade any tissue of the body, since it activates 
oncogenes and inactivates tumor suppressor genes. As a result, the majority of cancers 
result from an alteration of genes involved in cell proliferation, differentiation, 
survival, and genomic stability (Chang & Kinghorn, 2001). Since earliest times, 
scientists were searching for natural plant extracts of efficient anticancer effect, with 
no or reduced effect against normal cells. Among alternatives of fighting against 
cancer, chemoprevention has been found to be a promising approach was applied. 
Chemoprevention is described as the intake of pharmaceutical or natural products to 
avoid or postpone carcinogenesis (Cragg & Newman, 2005). The majority of 
chemotherapeutic drugs applied in cancer treatments are obtained from plant extracts 
or their synthetic products. Around 60% of drugs used in cancer treatments are isolated 
from plants. These include Podophyllum lignans, Camptotheca alkaloids, Taxus 
diterpenes, and vinca alkaloids (Solowey et al., 2014).  
1.2 The Daucus carota, carota ssp. 
1.2.1 Plant description 
Daucus carota (Linnaeus) ssp. carota also known as wild carrot, belongs to the 
family Umbelliferae (Apiacae). The Umbelliferae is characterized by sweet-smelling 
plants and void stems. It is a major family of flowering plants consisting of 434 genera 
and 3700 species. Some members of the Umbelliferae are essential sources of food, for 
instance Daucus carota ssp. sativus which is the commonly edible carrot all over the 
world. Others plants in the same family are used as food flavoring agents since they are 
abundant in odoriferous composites. Wild carrot has many names including Bird's Nest 
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Weed, Queen Anne's Lace, Devils Plague, Bishop’s weed, Bee's Nest Plant, and Garden 
Carrot. It is an irregular biennial plant (around 1m height) that grows in dry lands and 
beside the roads (Mitich, 1996). The plant is characterized by a tall stem, arising from 
fleshy, harsh, white-colored, branched root which is characterized by an aromatic smell 
and a pleasant taste. The leaves are bi-pinnate, arranged on both sides of the leafless stalk 
which ends in a compound umbel made up of mini white flowers. Each umbel has spiral 
foliage at its base. Before maturation, the umbels are light pink, and then brilliant white 
and concave upon maturation. The center of the flower is light reddish, it is the flower’s 
seed that turn into brown when the flower is mature. The carrot seeds are long, rounded, 
and convex in shape. They are somewhat ciliated, and distinguished by its pleasant, 
aromatic odor, and a relatively bitter flavor. The carrot medicinal properties are owing to 
a colorless or pale yellow volatile oil. Once maturation is complete, the umbels close and 
acquire a spheroid shape (Mills, 1994). Flowering starts in June and ends up in September 
(McGuffin, Hobbs, Upton, & Goldberg, 1997). A compound umbel may comprise 
hundreds of tinny flowers and go up to 11 cm diameter (Hoffmann, 1990). 
 
Figure 1: Daucus carota ssp. carota umbel (Elpel, 2004). 
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1.2.2 Geographical distribution 
Wild carrot is primarily endemic to Western Asia and the Mediterranean, however, 
it also appears in Tropical Africa, Australia and America (Reed, 1976). It arose in 
Afghanistan, then in the 13-14th century it extended to China. Soon afterward, it reached 
England in the 15th century. This plant is reported in Europe (England, Germany, Poland, 
Greece, Hungary, Austria, Sweden), Africa (Mauritius, Egypt, Tunisia), America 
(Canada, USA, Puerto Rico), and Asia (Iraq, Jordan, Lebanon, Iran) (Holm, Pancho, 
Herberger, & Plucknett, 1979; Ross, 2007).  Daucus carota can withstand temperatures 
ranging between 3.6 and 28.5 ºC, and a soil pH fluctuating between 4.2 and 8.7 (Duke, 
1978).  
1.2.3 Plant metabolites 
Plants are made up of primary and secondary metabolites. Primary metabolites are 
required for cell growth while secondary metabolites have an unknown function, but it 
was stated that they act as a defense to fight pathogens. Now, essential secondary 
metabolites are extracted from plants and applied in phytomedicine. Various secondary 
metabolites are virulent to bacteria and viruses (Wyk & Wink, 2004). Earlier studies 
revealed that secondary metabolites isolated from numerous plants showed favorable 
anticancer and antioxidant characteristics (Silva et al., 2011). These secondary metabolites 
are categorized into phenolics, terpenes, alkaloids, glycosides, saponins... 
1.2.3.1 Phenolics 
Phenolics compounds are composed of one or several aromatic rings with one or 
several hydroxyl groups. The simplest form of phenolics is phenol (C6H5OH). These 
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secondary metabolites are highly present in plants. They give give the plant its color and 
they act as a defense against pathogens, parasites, and predators. Phenolics are present in 
vegetables, legumes, cereals, olives, and fruits. They include flavonoids, phenolic acids, 
lignans, coumarins, stilbenes, and tannins (Dai & Mumper, 2010). 
Flavonoids structure consists of two phenyl rings and a heretocyclic ring. 
Depending on the molecular structure, flavonoids are divided into subgroups which 
comprise flavonols, flavones, flavanols, anthocyanins, isoflavones, flavanones. 
Flavonoids are constituents of vegetables, fruits, wine and tea. For instance, malvidin and 
cyanidin which belongs to the anthocyanins subgroup, are abundant in beans, berry fruits, 
cabbage, and red rice (D Archivio et al., 2007). 
The second essential group of phenolics which is abundant in plants, is phenolic 
acids. This group is divided into two subgroups: derivatives of benzoic acid, and 
derivatives of cinnamic acids (D Archivio et al., 2007). 
Another essential group of polyphenolics is tannins. This group is divided into two 
subgroups: hydrolysable and non-hydrolysable (condensed) tannins. These complex 
polyphenolic compounds can be hydrolysed into phenolic acids and sugars by enzymatic 
and non-enzymatic hydrolysis. Tannins are constituents of red wine, immature fruits, and 
food condiments (Khanbabaee & van Ree, 2001). For example, resveratol is the major 
tannin in red wine (Fresco, Borges, Diniz, & Marques, 2006).  
1.2.3.2 Terpenes 
Terpenes are a wide and varied group of organic compounds that are derived from 
microorganisms, insects, animals, and plants. Terpenes are the primer constituents of resin 
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and turpentine which is made from resin. Terpenoids results from either oxidation 
reactions of terpenes, or rearrangement of its carbon skeleton. Essential oils extracted from 
a large and diverse plant species are rich in terpenes and terpenoids. Terpenes are made 
up of isoprene (C5H8) units, and classified according to the number of isoprene units in a 
molecule (Breitmaier, 2006). 
Table 1: Classes of terpenes. 
Name Number of 
isoterpene 
units 
Molecular 
formula 
Examples 
Hemiterpenes One C5H8 - 
Monoterpenes Two C10H16 Limonene, Terpineol 
Sesquiterpenes Three C15H24 β-caryophyllene, Humulene 
Diterpenes Four C20H32 Cembrene, Taxadienne 
Sesterterpenes Five C25H40 Geranylfarnesol 
Triterpenes Six C30H48 Squaline 
Sesquaterpenes Seven C35H56 Ferrugicadiol, 
Tetraprenylcurcumene 
Tetraterpenes Eight C40H64 Acyclic lycopene, α- and β-
carotenes 
Polyterpenes Many - Rubber 
 
 
1.2.3.3 Alkaloids 
Alkaloids are nitrogen containing compounds of natural origin. These natural 
compounds are synthesized by plants, bacteria, fungus, and animals. Alkaloids are 
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classified as polyamine alkaloids, protoalkaloids, true alkaloids, and pseudalkaloids. 
Among clinically used alkaloids, morphine and codeine are used as analgesics. Vincristine 
and vinblastine are used to inhibit the growth of tumors (Nash, Watson, Asano, & Pelletier, 
1996).  
1.2.4 Phytochemical screening of wild carrot 
Investigations of Daucus carota oil extract from Portugal and Sardinia revealed 
significant dissimilarities in essential oil composition. In fact, phenylpropanoids (15.2%) 
(dominated by E-methylisoeugenol (10.0%)), and hydrocarbon sesquiterpenes (61.6%) 
(dominated by 11αH-himachal-4-ene-1-β-ol (9.0%) and β-bisabolene (51.0%)) are the 
major components of the mature and flowering umbel’s oil growing in Sardinia. However, 
hydrocarbon monoterpenes (19.3%) (dominated by α-pinene (13.0%)) and oxygenated 
monoterpenes (68.7%) (dominated by geranyl acetate (65.0%)) are the most predominant 
components of the mature umbel’s oil growing in Portugal (Maxia et al., 2009). 
 Another study on Daucus carota oil extract from Corsica showed that 
monoterpene hydrocarbons (38.6%), phenylpropanoids (45.8%), and sesquiterpenes 
(11.1%) are the main components, associated with minor quantities of oxygenated 
monoterpenes, and traces of diterpenes. The phenylpropanoids include elemicin (11.4%) 
and (E)-methylisoeugenol (33.0%) as main constituents. α-pinene (24.9%) noticeably 
dominated the monoterpene hydrocarbons, however, limonene (2.2%), myrcene (3.5%), 
and sabinene (3.7%) were existing in reduced quantities. 11αH-himachal-4-en-1β-ol 
(1.6%) in addition to β-bisabolene (4.4%) are the major components of sesquiterpene 
(Gonny, Bradesi, & Casanova, 2004).  
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Essential oil extracted from the seeds of wild carrot from Lithunia belongs to the 
sabinene chemovar, a bicyclic monoterpene (28.2- 37.5%). Moreover, limonene (2.3-
4.0%), γ-terpinene (2.9-6.0%), terpinen-4-ol (4.6-7.5%), and α-pinene (16.0-24.5%) are 
the major components of this essential oil (Mockute & Nivinskiene, 2004).  
“Nanheshi” is the popular name of the wild carrot fruit in China. This fruit contains 
mainly flavonoids, steroids, long chain alkane, ginsenode, guaiane sesquiterpenes, and 
eudesmane sesquiterpenes. Furthermore, a natural eudesmane sesquiterpenes was isolated 
from “Nanheshi” and is referred to daucucarotol (Fu, Zhang, Yi, Feng, & Tian, 2010).  
In India, the essential oil from the seeds of the wild carrot (Daucus carota L. ssp. 
carota) contains a sesquiterpene named carota-1,4-β-oxide (R. Dhillon, Gautam, Kalsi, & 
Chhabra, 1989).  
Therefore, geographical distribution of the plant and the plant organ are both key 
factors in determining the chemical composition of the oil extract. 
1.2.5 Pharmacological properties of wild carrot 
1.2.5.1 Antimicrobial activity of wild Carrot 
The oil extracted from the umbel of wild carrot at the end of the blooming stage 
revealed anti-bacterial activity against Campylobacter jejuni which causes gastroenteritis. 
The growth of Campylobacter coli, Campylobacter jejuni, and Campylobacter lari strains 
was inhibited when treated with the polar oil extract containing mainly elemicin (33.6%) 
and (E)-methylisoeugenol (41.8%) (Rossi et al., 2007).  
Moreover, the oil extracts from the different parts of wild carrot and from the seed 
of cultivated carrot (Daucus carota L. ssp. sativus) growing in Poland were analyzed for 
their antibacterial activity. They were tested on two fungi species and four bacteria 
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species.  Results revealed that gram-positive bacteria (Staphyloccocus aureus, Bacillus 
subtilis) were highly susceptible to the different oil extracts. Furthermore, the oil extracted 
from mature umbels exhibited the most potent antibacterial activity with a minimum 
inhibitory concentration (MIC) of 3-4 μL/mL. The rest of the oil extracts showed the 
lowest antimicrobial activity against Pseudomonas aeruginosa and Penicillium expansum. 
The oil extracted from mature umbels of wild carrot plant showed the highest 
antimicrobial activity against gram-negative bacteria (MIC, 3 and 8 μL/mL) compared to 
the oil extracted from blooming umbels (MIC ≥ 8 μL/mL) (Staniszewska, Kula, 
Wieczorkiewicz, & Kusewicz, 2005).  
Daucus carota oil extract from plants growing in Sardinia showed high antifungal 
activity (MIC 0.16-0.64 μL/mL). However, this oil showed an irregular inhibition pattern 
against a number of fungal strains. For instance, Aspergillus and Candida strains were less 
sensitive to the oil extract compared to dermatophyte and C. neoformans strains (Maxia 
et al., 2009). Previous studies showed that 20% of mice infected with helicobacter pylori 
and treated with DCOE were cured (Bergonzelli, Donnicola, Porta, & Corthesy-Theulaz, 
2003). Another study also revealed a high antimicrobial activity of the Daucus carota 
methanolic extract against the endemic bacteria Bacillus cereus which causes food borne 
illness. The MIC was approximately 0.01 mg/mL (Kumarasamy, Cox, Jaspars, Nahar, & 
Sarker, 2002; Valero & Salmeron, 2003).  
1.2.5.2 Antioxidant activity of wild carrot 
 Previous work in our lab showed that DCOE has a strong antioxidant activity, this 
may be attributed to the presence of polyphenols and phenolic compounds. The 
antioxidant activity of these phenolics is explained by many mechanisms. For instance, 
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they prevent the formation or scavenge radical species by inhibiting some enzymes or 
chelating metals that produce free radicals (Dai & Mumper, 2010). Results revealed that 
the radical scavenging activity of DCOE and Trolox is 61% and 90.8% respectively, thus, 
DCOE has a significant radical scavenging activity. Moreover, results of the FRAP assay 
showed that DCOE probably work as an electron donor or react with free radicals and 
convert them into stable compounds (Shebaby et al., 2013).   
Another study in our lab revealed that among the different DCOE fractions, F3 
fraction has the highest scavenging activity with an IC50 equal to 0.29 ± 0.01 mg/ml. Also, 
the same study revealed that F4 fraction has the highest FRAP value (437.59 ± 6.94 µmol 
FeSO4/g). The high antioxidant activity of F3 and F4 could be associated with the presence 
of various phenolic and flavonoid compounds (Shebaby et al., 2015b). The antioxidant 
activity of these phenolics might be explained by the existence of hydrogen donating OH 
groups on their aromatic rings (Heijnen, Haenen, Minou Oostveen, Stalpers, & Bast, 2002; 
Kim & Lee, 2004).  
1.2.5.3 Antitumor activity of wild Carrot 
A study conducted in our lab investigated the activity of DCOE against two-stage 
chemical skin carcinogenesis in mice (DMBA/TPA). Intraperitoneal treatment showed a 
chemopreventive effect against tumor, topical treatment revealed a dose-dependent 
inhibition of the tumor, however, gavage treatment exhibited a mild effect. These results 
proved that DCOE has an anticancer activity against a DMBA/TPA skin tumorigenesis 
model in mice (Zeinab et al., 2011).  
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Another study revealed that DCOE exhibited a selective cytotoxicity in AML cell 
lines. It induced apoptotic cell death probably through the MAPK pathway (Tawil, 
Bekdash, Mroueh, Daher, & Abi-Habib, 2014). 
 A previous work also investigated the antitumor activity of DCOE against HT-29, 
Caco-2 human colon cancer cells, and MCF-7, MDA-MB-231 breast cancer cells. DCOE 
revealed a decrease in cell proliferation and a dose-dependent cytotoxicity against HT-29, 
Caco-2, MCF-7, and MDA-MB-231 cancer cells. These results demonstrated that DCOE 
has an antitumor activity against human colon and breast cancer cells (Shebaby et al., 
2013).  
 Earlier study in our lab revealed that DCOE fractions (F1 and F2) had a significant 
antitumor activity against MDA-MB-231 breast cancer cells. The cell death was apoptotic 
and it was chiefly mediated through the Erk pathway (Shebaby et al., 2014).  
 Another work revealed that DCOE fractions (F1 and F2) had a potent anticancer 
activity against HT-29 and Caco-2 human colon cancer cells. F1 and F2 induced apoptosis 
and cell cycle arrest mainly through the suppression of the MAPK/Erk and PI3K/Akt 
pathways (Shebaby et al., 2015a). 
The treatment of glioblastoma, breast, skin, and lung cancer cells with DCOE F2 
fraction, the most potent fraction, showed a decrease in cell motility, invasion, and an 
increase in cancer cell adhesion. Also, The activation of CDC42, Rac, and ρ-GTPases 
decreased upon treatment, this might explain the fact that F2 fraction reduces cell motility 
(Zgheib et al., 2014).  
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1.2.5.4 Traditional uses of wild carrot  
Wild carrot (Daucus carota L. ssp. carota) possesses diuretic, carminative, antispasmodic, 
and antilithic characteristics. In folk medicine, it was recommended to treat chronic 
dysentery, urinary and kidney calculus, dropsy, cystitis, kidney ailments, gout problems, 
infections of the bladder, lithuria, jaundice, obstructions of the viscera, and scurvy 
(Nadkarni, 1976; Wyk & Wink, 2004). Traditionally, in Europe, volatile oil from wild 
carrot was used in urinary anti-inflammatory and antiseptic treatment for prostatitis and 
cystitis (Hoffmann, 1990).  
1.3 Cancer 
1.3.1 Introduction 
Almost all body cells maintain a balance between cell renewal or division and cell 
death, in order to keep the total amount of any particular type of cell constant. When body 
cells die, stem cells generate new cells that differentiate to substitute dead cells. 
Sometimes, cell growth and division are uncontrollable; as a result, clones of cells greatly 
proliferating give rise to a tumor or neoplasm. Two types of tumor have been identified: 
benign and malignant.  A benign tumor doesn’t spread into surrounding tissues, however, 
a malignant tumor proceeds with abnormal growth and invades neighboring tissues. 
Cancer belongs particularly to malignant tumor. Moreover, a process known as metastasis 
occurs when a tumor (primary tumor) spread to other tissue sites (secondary tumor) via 
blood or lymph vessels (Hanahan & Weinberg, 2011). Despite the therapeutic 
enhancement developed to understand carcinogenesis, cancer is the second reason of death 
in the United States, also it is estimated to exceed heart diseases as the main reason of 
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death in the upcoming years (Siegel et al., 2015). Thus, chemotherapy becomes a primary 
field of investigations. Cancer growth is generally assigned to environmental aspects and 
less interestingly to genetics. Usual environmental factors comprise environmental 
pollutants, varied lifestyles, radiations, and infections (Manton, Akushevich, & 
Kravchenko, 2011). 
1.3.2 Classification: 
Malignant tumors are categorized to several types based on their origin. 
Carcinomas are malignant tumors arising from epithelial cells or ectodermal and 
endodermal tissues. This group denotes the majority of prevalent cancers (prostate, breast, 
colon, and lung cancer). Cancer cells originating from connective tissues of the mesoderm 
as nerve, fat, cartilage, and bone are referred to as sarcomas. Other types of malignancies 
are leukemia and lymphoma which arise from hematopoietic cells. Cancers derived from 
pluripotent cells are referred to as germ cell tumor. Finally, blastic tumor or blastoma are 
neoplasm originating from embryonic cells or immature cells (Hanahan & Weinberg, 
2011). 
 
1.3.3 Carcinogenesis: 
Carcinogenesis is the conversion of a normal cell to malignant cell through a multi-
step approach which takes long duration. The first step of carcinogenesis is initiation 
which consists of an adduct formation between the chemical carcinogen and a nucleotide 
in the DNA of a cell. Initiation provokes genetic predisposition or dormancy where the 
cells stop dividing and live in a dormant state until appropriate environmental 
circumstances occur and the cells proliferate again. Faltering initiation is an important step 
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in cancer treatment. The second step, known as promotion, is a prolonged step which may 
take place over a period of time extending from a few months to years. Throughout this 
step, patients who adjust the way in which they live and they eat may avoid the 
development of cancer during their lifespan. The third step is known as progression in 
which cancer spreads. Throughout this step, adjustment of lifestyle and diet is useless 
(Hanahan & Weinberg, 2000; Reddy et al., 2003). 
1.4 Leukemia 
1.4.1 Introduction 
Leukemia is a cancer that appears in cells that mature into various kinds of blood 
cells. Leukemias are classified according to two main factors: the cell type and the degree 
of maturation. Acute leukemias develop in immature stem cells known as blasts which 
grow rapidly. However, chronic leukemias develop in mature cells and are considered 
slow growing. Myeloid leukemias develop in myeloid cells lacking complete 
differentiation. These cells will differentiate into red blood cells, white blood cells (except 
lymphocytes), and megakaryocytes. However, lymphocytic leukemias develop in 
immature lymphocytes. Thus, leukemias are classified into four essential types which are 
the followings: acute myeloid leukemia (AML), acute lymphocytic leukemia (ALL), 
chronic myeloid leukemia (CML), and chronic lymphocytic leukemia (CLL) (Turgeon, 
2005). 
1.5 Acute myeloid leukemia (AML) 
1.5.1 Definition: 
Almost all adult leukemia patients suffer from acute myeloid leukemia with around 
20,830 new cases and 10,460 deaths estimated in the United States in 2015. AML is more 
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prevalent in men than women (Siegel et al., 2015). Around 45% of patients with myeloma 
survive 5 years after identification (Bugos, 2015). However, the five year survival 
percentage in 65 years-old patients is only 5% due to some prognostic factors as age, the 
presence of a disease co-existing with a main disease, and cytogenic defects (Sherman et 
al., 2013). AML is a fatal disease that begins in the bone marrow. It is categorized by the 
fast and irregular development of the myeloid cells which interrupt the differentiation of 
the cells in the bone marrow, leading to a reduced production of normal cells, and a build-
up of crappy differentiated immature stem cells in the bone marrow, spleen, and liver 
(Estey & Döhner, 2006). 
Myelodysplasia, hereditary diseases, ecofactors or medications, and new gene 
mutations are biological mechanisms involved in acute myeloid leukemia. The symptoms 
of AML are associated with the lack of normal blood cells, resulting in the development 
of anemia, neutropaenia, and leukemic cell infiltration of the bone marrow and various 
tissues (Lowenberg, Downing, & Burnett, 1999). Two predominant categorizations for 
AML exist. The World Health Organization (WHO) classified AML according to the 
molecular genetics, cytogenetics, morphology and immunological markers (Vardiman, 
Harris, & Brunning, 2002).  
1.5.2 Leukemia-initiating cells (LICs) 
As hematopoiesis requires hematopoietic stem cells (HSCS) that differentiate into 
different type blood cells, similarly, acute myeloid leukemia necessitates leukemia-
initiating cells (LICS) that give rise to irregular immature stem cells (Taussig et al., 2010). 
Moreover LICS share many characteristics with HSCS such as: pluripotency, self-renewal, 
and maintaining a quiescent state (Schubbert et al., 2014; Takeishi et al., 2013). 
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A major issue in dealing with leukemia is that the dormant LICs are mainly 
unaffected by usual radiation and chemotherapy which target cells experiencing DNA 
replication and are consequently ineffective in eradicating dormant cells (Clevers, 2011; 
Huntly & Gilliland, 2005). Malignant cells may be reinitiated after dormancy if LICs are 
not destroyed (Takeishi et al., 2013). Destroying LICs is a key to cure AML, thus, knowing 
their phenotype is essential. It was suggested that LICs exist in the CD34+ CD38− cells of 
AML. But, Taussig et al. (2010), demonstrated that the LICs phenotype is heterogeneous, 
as a result targeting their surface antigens is inefficient. 
1.5.3 Molecular process of AML 
AML are defects of hematopoietic progenitor cells which are distinguished by 
somatic changes of a gene’s structure targeting translocations and inversions. Fusion 
oncogenes that use analogous signal transduction and transcriptional activation pathways 
to promote leukemia have been identified. AML is characterized by translocations of 
chromosomes that involve transcription factors required for regular differentiation of 
myeloid progenitors. As a result, translocations lead to dysfunctional transcription factors, 
and thus to faulty differentiation. Nevertheless, without help, translocations are not enough 
to generate AML. Some data reinforce the theory that second mutations are necessary. 
Acute myeloid leukemia pathogenesis occurs in several steps. Class I mutations as 
activation of point mutations in FLT3 and c-KIT which are receptor tyrosine kinases, 
afford a survival or a proliferation stimulus to hematopoietic progenitor cells. Class II 
mutations target hematopoietic transcription factors and serves mainly to damage 
differentiation and later apoptosis. These two processes of mutations lead to leukemic cells 
that proliferate, survive, but don’t differentiate. Targeting these two classes of mutations 
through small inhibitor molecules is considered a therapeutic and a clinical suggestion. 
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Examination of the molecular genetics of AML affords insights into cogent targeted 
therapeutic treatments (Gilliland, 2002). 
1.5.4 AML treatments 
Treatment of AML is divided into two steps which are the followings: remission 
induction and post-remission consolidation. The purpose of induction is to eradicate the 
leukemic cells so that normal hematopoiesis is restored. For the past thirty years, 
Anthracycline and cytarabine were used for this achievement (Döhner et al., 2010). 
Remission rates varied between 65 and 85% in patients aging less than sixty years old. 
The side effects of induction chemotherapy are the suppression of the marrow and thus 
the patient will require RBCs and platelets. Moreover, the patient’s condition may 
complicate due to neutropenic sepsis. Fatigue, nausea, vomiting, diarrhea, gastrointestinal 
and cerebellar toxicity, bleeding, and loss of fertility are also common adverse 
consequences. With the induction, granulocyte colony stimulating factor (G-CSF) and 
granulocyte/macrophage colony stimulating factor (GM-CSF) are used after 
chemotherapy to increase the count of white blood cells, however, they don’t have any 
effect on the remission rate and duration. The purpose of consolidation chemotherapy is 
to destroy completely any remaining tumor in order to attain healing (Smith et al., 2004). 
It consists of severe chemotherapy, extended maintenance, and allogeneic or autologous 
hematopoietic stem cell transplantation (Löwenberg, Griffin, & Tallman, 2003). 
Maintenance is a phase where less intensive chemotherapy is assigned for two to three 
years. In order to give high dose chemotherapy, patients should get a bone marrow 
transplant (BMT) which is divided into two types based on the origin of the hematopoietic 
stem cells. Allogeneic BMT is commonly used to treat AML. In fact, hematopoietic stem 
cells are taken from a donor whose HLA is closely similar to that of the patient. Allogenic 
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BMT are useful because of ‘graft-versus-leukaemia’ effect which diminishes relapse 
possibility. However, one main adverse effect of Allogenic BMT is the graft-versus-host 
disease (Smith et al., 2004). Moreover, Non-myeloablative transplant (mini-transplant) is 
mainly used in elderly patients who can’t tolerate high doses of chemotherapy. In fact, 
these patients get low doses chemotherapy, which doesn’t entirely eradicate the cells in 
the marrow, followed by allogenic transplant. Thus, the donor immune system recognizes 
the leukemia cells as foreign and destroys them. Though, one major complication is also 
the graft-versus-host disease (Ball & Egeler, 2008; Peccatori & Ciceri, 2010). Autologous 
BMT are used for AML patients who are in a period of short-term recovery after primary 
treatment and who don’t have a harmonizing donor. Some evaluate the Autologous BMT 
as a consolidation therapy. Autologous BMT uses the patient’s hematopoietic stem cells 
which are taken from his peripheral blood or bone marrow. One main disadvantage of this 
transplant is that there is possibility of having some leukemia cells in the autograft (Smith 
et al., 2004).  
1.6 Aims of the study 
Previous work in our laboratory revealed that the methanolic and the aqueous extracts of 
the Daucus carota umbels displayed and antiulcer and anti-inflammatory effects (Wehbe, 
Mroueh, & Daher, 2009). Also, DCOE exhibited an anticancer activity against AML, 
human colon, and breast cancer cells (Shebaby et al., 2013; Tawil et al., 2014). A 
DMBA/TPA skin tumorigenesis model in mice treated with DCOE revealed an anticancer 
activity. Also, it has an antioxidant activity against some breast and human colon cancer 
(Shebaby et al., 2013; Zeinab et al., 2011). Moreover DCOE pentane (F1) and pentane 
diethyl ether (F2) fractions had a potent anticancer activity against human colon, and 
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breast cancer cells (Shebaby et al., 2015a; Shebaby et al., 2014). DCOE F2 fraction, which 
is the most potent, decreased cell motility, invasion, and increased cancer cell adhesion in 
glioblastoma, breast, skin, and lung cancer cells (Zgheib et al., 2014). Yet, the effects of 
the Daucus carota major compound β-2-himachalen-6-ol have not been explored in AML 
cancer cells. The aim of the present work is to: 
 Study the composition of DCOE obtained from various plant organs and find out 
the effect of geographical distribution even when it comes to plants collected from 
the same country. 
 Assess the percentage composition of β-2-himachalen-6-ol, the major component 
of the pentane diethyl ether fraction (F2 fraction), in open and closed umbels 
collected from three different altitudes.   
 Purify the major compound β-2-himachalen-6-ol using silica gel column 
chromatography and test its anticancer activity against five AML cell lines: Mono-
Mac-1, HL60, KG1, ML2, and U937.  
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CHAPTER 2 
 MATERIALS AND METHODS 
2.1 Chemical analysis: 
2.1.1 Sample collection  
Daucus carota (Linnaeus) ssp. carota was identified based on the characteristics 
described in the “Handbook of Medicinal Herbs” by van Wyk (2004) and affirmed by Dr. 
Ahmad Houri. The different plant parts were collected from two different locations 
(Amioun and Mounsif) in order to assess the percent composition of the major compound 
β-2-himachalen-6-ol. In addition to that, open and closed umbels of Daucus carota were 
collected from three different altitudes: sea level, 200 and 500 m, in order to study the 
effect of altitude on the chemical composition of the extracted oil. Since closed umbels 
contain the highest percentage of β-2-himachalen-6-ol, they were collected at the post 
flowering period between July and August from their natural habitat in Lebanon. Umbels, 
leaves, stems and roots were air dried in the shade, cut into small pieces and then subjected 
to extraction in methanol/acetone (1:1) for 48-72 hrs. The extract was then filtered and 
evaporated (40ºC) under reduced pressure in a rotary evaporator to obtain a crude Daucus 
carota oil extract (DCOE) which was then dried over anhydrous magnesium sulfate. The 
average yield of DC oil extracted from umbels was 3.5% w/w and the collected oil was 
stored in a closed amber bottle at 4°C until further fractionation.  
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2.1.2 Oil Fractionation 
       First generation F1, F2, F3 and F4: 
  The DC oil extracted from umbels (30 g) was chromatographed on a silica gel 
column (230–400 mesh; 47 by 2.5 cm). The first fraction (F1; 7.92 g; colorless) was eluted 
with hexane (100%; 1L), the second fraction (F2; 8.12 g; yellow) with hexane: ethyl 
acetate (9:1; 1L), the third fraction (F3; 6.41 g; dark green) with hexane: ethyl acetate (8:2; 
1L) and the fourth fraction (F4; 5.42 g; dark green) with hexane: ethyl acetate (7:3; 1L). 
Fractions were analyzed via TLC using hexane: ethyl acetate (7:3). Plates were stained 
using a 2% anisaldehyde solution.  
Second generation F2: 
F2 (10 g) was chromatographed on a silica gel column (230–400 mesh; 47 by 2.5 
cm). The first fraction (F2.1; 3.6 g, yellow) was eluted with hexane: ethyl acetate (9:1; 0.5 
L), the second fraction (F2.2; 3.3 g, dark green) with hexane: ethyl acetate (8:2; 0.5 L), 
and the third fraction (F2.3; 2.7 g, dark green) with hexane: ethyl acetate (7:3; 0.5 L). 
Fractions were analyzed via TLC using hexane: ethyl acetate (7:3). Plates were stained 
using 2% anisaldehyde solution.  
Third generation F2.1.4: β-2-himachalen-6-ol 
F2.1 (1 g) was chromatographed on a silica gel column (230–400 mesh; 47 cm by 
2.5 cm) whereby the oil extract was eluted with hexane: ethyl acetate (9:1; 0.5 L followed 
by 8:2; 0.5 L followed by 7:3; 0.5 L). β-2-himachalen-6-ol (100-300 mg; 95-98% purity) 
was collected as a yellow oil based on an Rf value of 0.70 in 7:3 hexane: ethyl acetate. β-
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2-himachalen-6-ol doesn’t absorb UV-Vis radiation but can be observed as a pink spot 
upon staining with anisaldehyde.  
2.1.3 Gas Chromatography and Mass Spectrometry (GC-MS) analysis  
        The composition of the DCOE and its fractions were analyzed using GC-MS 
(Hewlett Packard, HP6890 series)  fitted with a  fused silica HP5-MS 5% phenyl methyl 
siloxane cap column (30 m × 0.25 mm i.d., film thickness 0.25) and directly coupled to 
the MS. The carrier gas was helium with splitless injection and the flow rate of 1.2 ml/min 
was applied. The temperature program was 2.0 min at 70 °C, 70- 130°C at 8°C/min and 
hold for 5 min, 130- 180°C at 2°C/min and hold for 10 min, 180- 220°C at 15°C/min and 
hold for 2 min and then 220- 280°C at 15°C/min and hold for 22 min. Identification of the 
components was performed by comparing their mass spectra with the literature (NIST11 
and W9). Percentage composition was computed from GC peak areas. 
2.2 Cytotoxicity assay 
A total of five AML cell lines were used in the present study: HL60, ML2, U937, 
KG1, and Mono-Mac-1. All cells were grown in RPMI and incubated at 37 °C in a 5% 
CO2 incubator. The cytotoxic effect of Daucus carota major compound, β-2-himachalen-
6-ol, on AML cell lines was investigated. 
A total of 104 cells/well (100 μL of cell suspension/well) were plated in a flat 
bottom 96 well plate. Then, 50 µL of β-2-himachalen-6-ol diluted in DMSO/RPMI, or just 
DMSO/RPMI, were added to create a range of eleven different concentrations which are 
three folds apart (from 0 μg/mL to 1 mg/mL). After 48 hours of incubation at 37º C and 
5% CO2, 50 µL of the cell proliferation reagent XTT (Roche, Basel, Switzerland) were 
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placed in each well and then incubated for 4 hours at 37 ºC and 5% CO2.  Later on, 
absorbance was read at 450 nm using an ELISA plate reader. The IC50 values were 
determined using the GraphPad Prism 5 software (GraphPad Software, San Diego, CA). 
2.3 Cell cycle analysis by flow cytometry 
 The influence of β-2-himachalen-6-ol on AML’s cell cycle was investigated by 
flow cytometry using Propidium Iodide (PI)-staining. In brief, cells were incubated with 
three different concentrations of β-2-himachalen-6-ol (1 mg/mL, 37.04 µg/mL, and 0.45 
µg/mL) and media only (control cells) in a flat bottom 96 well plate that was incubated 48 
hours at 37º C and 5% CO2. Cells were harvested and fixed in 70% ethanol. Later on, cells 
were frozen at -20ºC for at least 24 hours. Cells were then incubated in 500 µL PI staining 
solution (50µg/mL) at 37ºC for 40 minutes. The amount of DNA was then measured on 
FL2-A of a C6 flow cytometer (BD Accuri, Ann Arbor, MI), and the percentage of cells 
in the various cell cycle phases (G0/G1, S and G2/M) was determined via gating for the 
cell population on width versus forward scatter. 
2.4 Cell cytotoxicity analysis by flow cytometry 
In order to verify whether cell death occurred via apoptosis or necrosis, an Annexin 
V-fluorescin Isothiocyanate (Annexin V-FITC) and Propidium Iodide (PI) labeled 
apoptosis/necrosis detection kit (Abcam, Cambridge, MA) and a FITC-conjugated active 
caspase inhibitor (ApoStat Apoptosis Detection Kit, R&D Systems, Abingdon, England) 
were used.  
In brief, cells were incubated with three different concentrations of β-2-
himachalen-6-ol (1 mg/mL, 37.04 µg/mL, and 0.45 µg/mL) or media only in a flat bottom 
96 well plate for 48 hours for active caspase staining and annexin V/PI staining at 37˚C/5% 
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CO2. Cells were then harvested and incubated with a FITC-conjugated annexin V 
antibody (2.5 mg/ml) and PI (5 mg/ml) in antibody binding buffer for 45 min at 37˚C or 
incubated with 0.5 μg/ml of apostat for 30 min then harvested. Cells were then read via a 
C6 flow cytometer. Annexin V/PI data was determined on FL1-H (annexin) versus FL2-
H (PI) scatter plot and active caspases were identified on FL1-H.  
2.5 Effect of MAPK pathway inhibition 
In order to study the effect of β-2-himachalen-6-ol on the inhibition of the MAPK, 
U0126, a small molecular weight mitogen-activated protein/extracellular signal-regulated 
kinase kinase 1/2 (MEK1/2) inhibitor (Cell Signaling Technology, Danvers, MA), was 
used. Briefly, 104 cells/well (100 μL of cell suspension/well) were plated in a flat bottom 
96 well plate. Then, a 24 μL of either media (control), β-2-himachalen-6-ol ( 50 µg/mL), 
20 µM of U0126, 50 µM of U0126, or a combination of β-2-himachalen-6-ol with each of 
U0126 concentrations mentioned above were added to each well. After 48 hours of 
incubation at 37º C and 5% CO2, 50 µL of the cell proliferation reagent XTT (Roche, 
Basel, Switzerland) were placed in each well, and then incubated at 37º C and 5% CO2 for 
4 hours. Absorbance was then read at 450 nm using an ELISA microplate reader. Data 
analysis was performed using Excel.  
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CHAPTER 3 
RESULTS 
3.1 Purification of β-2-himachalen-6-ol   
3.1.1 Composition of DCOE from different parts of Daucus carota 
Daucus carota were collected from two different locations in order to assess the 
percent composition of the major compound β-2-himachalen-6-ol in their different parts 
(stems, roots, leaves and umbel) and to find out if the composition of DCOE varies 
between different locations in Lebanon. Therefore, the different parts of the plant were 
soaked in methanol/acetone (50/50) for 72 hours, and samples from the filtrates were run 
on GC-MS to identify the percentage components. The results of the GC-MS are shown 
in the tables 2 and 3 below. A sample of GC-MS chromatogram obtained from a Daucus 
carota umbel is also shown in figure 2. 
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Table 2: Daucus carota oil extract percent composition in roots, stems, leaves and umbels 
collected from Amioun and Monsif area. Identified components of > 2% are listed below. 
Component Rt* Root Stem Leaf Umbel 
  A* M* A M A M A M 
Benzene, tert-butyl- 4.945 - - - - - 38.69 - 6.62 
α-longipinene 11.712 - - - - - - - 8.58 
1,4,7,-Cycloundecatriene, 1,5,9,9- tetramethyl-, Z,Z,Z- 14.942 - 2.69 - - - - - - 
Humulene 14.953 - - - - - - - 6.89 
Germacrene D 16.010 4.17 16.73 - - - 5.59 2.39 - 
β-Selinene 16.221 - - - - - - 9.26 2.94 
α-Selinene 16.575 - - - - - - 3.57 - 
β-Himachalene 16.799 - - - - - - - 2.79 
β-Bisabolene 17.096 - - - - - - 5.84 12.72 
Shyobunone 17.330 6.27 - 4.05 - 8.47 - 3.30 - 
Elemicin 19.193 - - - - - - 12.46 8.48 
β-2-himachalen-6-ol 23.063 - - - - - - - 49.67 
Dodecyl acrylate 25.600 5.48 - - - - - - - 
2-Propenoic acid, oxybis(methyl-2,1-ethanediyl) ester 25.612 - - - - 6.92 - - - 
Tridecyl acrylate 25.614 - - 2.05 - - - - - 
Palmitic acid, methyl ester 36.808 4.11 - 5.27 - - - 5.41 - 
Linoleic acid, methyl ester 45.411 8.10 - 6.59 - - - - - 
11,14-Octadecadienoic acid, methyl ester 45.421 - - - - - - 7.98 - 
Linolenic acid, methyl ester 45.824 - - 8.50 - - - 7.52 - 
Phenol, 2,2'-methylenebis[6-(1,1-dimethylethyl)-4-
methyl- (Antioxidant 2246) 
56.152 - - - 14.13 8.06 - - - 
13-Docosenoic acid, methyl ester 57.167 - - - - 9.14 - 6.75 - 
13-Docosenamide, (Z)- 59.505 28.77 7.06 - - - - 10.02 - 
Oleamide 59.507 - - 6.87 - 52.53 - - - 
β-Sitosterol 67.256 7.86 2.35 - - - - - - 
Rt*: Retention time. 
A*: Amioun. 
M*: Mounsif. 
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Table 3: Daucus carota oil extract percent composition in roots, stems, leaves and umbels 
collected from Amioun and Mounsif area. Unidentified components of > 2% are listed 
below. 
Component Rt* Root Stem Leaf Umbel 
  A* M* A M A M A M 
Unidentified A 4.951 - 4.42 - 4.93 - - - - 
Unidentified B 6.752 - - - 3.44 - 6.94 - - 
Unidentified C 15.205 - 2.27 - - - - - - 
Unidentified D 16.325 - 11.18 - - - - - - 
Unidentified E 16.577 - 6.39 - - - - - - 
Unidentified F 19.881 - - - 10.56 - - - - 
Unidentified G 21.325 2.68 - - - - - 4.06 - 
Unidentified H 21.326 - - - - 5.50 - - - 
Unidentified I 22.765 - - - - - - 3.35 - 
Unidentified J 47.690 5.40 - - - - - - - 
Unidentified K 51.584 - - - 5.22 - - - - 
Unidentified L 51.591 - - 2.25 - - - - - 
Unidentified M 53.607 - 2.16 - - - - - - 
Unidentified N 57.035 - - - - - - 8.13 - 
Unidentified O 57.036 -  - - 9.39 - - - 
Unidentified P 57.042 - - - - - 19.17 - - 
Unidentified Q 57.054 - 2.32 - 10.78 - - - - 
Unidentified R 57.055 - - 6.70 - - - - - 
Unidentified S 57.174 - 2.25 5.19 - - - - - 
Unidentified T 57.179 - - - - - 22.11 - - 
Unidentified U 57.180 - - - 9.07 - - - - 
Unidentified V 57.255 - - 13.54 - - - - - 
Unidentified W 57.300 - - - 5.23 - - - - 
Unidentified X 57.311 - 3.15 - - - - - - 
Unidentified Y 57.585 - 8.07 - 6.79 - - - - 
Unidentified Z 57.595 2.29 - - - - - - - 
Unidentified AA 57.602 - - - - - 4.26 - - 
Unidentified AB 57.614 - - - 5.40 - - - - 
Unidentified AC 57.636 - - - - - 3.24 - - 
Unidentified AD 57.638 - - 7.54 - - - - - 
Unidentified AE 57.642 - 17.57 - - - - - - 
Unidentified AF 57.647 17.36 - - - - - 2.72 - 
Unidentified AG 57.666 - - - 13.46 - - - - 
Unidentified AH 57.678 - - 4.47 - - - - - 
Unidentified AI 57.775 - - 15.86 7.92 - - - - 
Unidentified AJ 59.523 - - - 3.08 - - - - 
Rt*: Retention time.  
A*: Amioun.  
M*: Mounsif. 
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Figure 2: Gas chromatogram of DCOE. 
3.1.2 Percentage composition of β-2-himachalen-6-ol in Daucus carota open and 
closed umbels and from different altitudes 
Based on the highest percentage composition of the major compound, β-2-
himachalen-6-ol, open and closed umbels of Daucus carota were collected from three 
different altitudes: sea level, 200 and 500 m. The oil extract was subjected to GC-MS 
analysis to determine the percent composition of β-2-himachalen-6-ol. Results are 
presented in tables 4 and 5. 
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Table 4: The efficiency of β-2-himachalen-6-ol in mature and immature Daucus carota 
umbels collected from three different altitudes in Mount Lebanon. Identified components 
of > 0.5% are listed below. 
Component Rt*  O.U.*   C.U.*  
  B.* BL.* H.* B.* BL.* H.* 
Tricyclo[5.4.0.0(2,8)]undec-9-ene, 2,6,6,9-tetramethyl-, 
(1R,2S,7R,8R)- 
11.712 2.63 - - 10.56 6.46 9.69 
Caryophyllene 13.735 - - - 1.33 1.41 0.55 
Humulene 14.953 20.13 - - 3.00 4.32 - 
Germacrene D 16.010 5.41 - - - - - 
α-Copaene 16.013 - - - - 1.24 - 
1H-Cyclopenta[1,3]cyclopropa[1,2]benzene, octahydro-7-methyl-3-
methylene-4-(1-methylethyl)-, [3aS-(3aα,3bβ,4β,7α,7aS*)]- 
16.021 - - - - - 0.53 
10s, 11s-Himachala-3(12),4-diene 16.102 - - - 1.32 - 0.97 
Naphthalene, 1,2,3,4,4a,5,6,8a-octahydro-4a,8-dimethyl-2-(1-
methylethenyl)-, [2R-(2α,4aα,8aβ)]- 
16.217 3.38 - 28.72 - - - 
Naphthalene, decahydro-4a-methyl-1-methylene-7-(1-
methylethenyl)-, [4aR-(4aα,7α,8aβ)]- 
16.221 12.25 - - - - - 
1H-Benzocycloheptene, 2,4a,5,6,7,8-hexahydro-3,5,5,9-tetramethyl-, 
(R)- 
16.799 - - - 3.12 1.60 2.39 
β-Bisabolene 17.096 4.84 - 19.89 - 4.64 - 
Benzene, 1,2,3-trimethoxy-5-(2-propenyl)- 19.216 - - 51.39 - - 0.86 
Isolongifolene,9,10-dehydro-4,7Methanoazulene, 1,2,3,4,5,6,7,8-
octahydro-1,4,9,9-tetramethyl-,[1S-(1.alpha.,4.alpha.,7.alpha.)]- 
22.543 - - - 1.95 - 2.23 
β-2-himachalen-6-ol 23.051 43.06 7.31 - 77.36 76.59 80.47 
Palmititc acid, methyl ester 36.808 6.23 - - - - - 
Rt*: Retention time. 
O.U.*: Open Umbels. 
C.U.*: Closed Umbels. 
B.*: Barbara. 
Bl.*: Blat. 
H.*: Hsarat. 
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Table 5: The efficiency of β-2-himachalen-6-ol in mature and immature Daucus carota 
umbels collected from three different altitudes in Mount Lebanon. Unidentified 
components of > 0.5% are listed below. 
Component Rt*  O.U.*   C.U.
* 
 
  B.* BL.* H.* B. BL. H. 
Unidentified A 16.098 - - - - 3.74 - 
Unidentified B 45.999 - - - - - 1.86 
Unidentified C 51.492 - 2.16 - - - - 
Unidentified D 51.590 - 3.93 - - - - 
Unidentified E 55.293 - 9.74 - - - - 
Unidentified F 57.059 - 7.79 - - - - 
Unidentified G 57.128 - 1.19 - - - - 
Unidentified H 57.231 - 6.57 - - - - 
Unidentified I 57.316 - 12.17 - - - - 
Unidentified J 57.647 2.07 29.29 - - - - 
Unidentified K 57.779 - 19.85 - - - - 
Unidentified B 45.999 - - - - - 1.86 
Unidentified C 51.492 - 2.16 - - - - 
Unidentified D 51.590 - 3.93 - - - - 
                                   Rt*: Retention time. 
                                   O.U.*: Open Umbels. 
                                   C.U.*: Closed Umbels. 
                                   B.*: Barbara. 
                                   Bl.*: Blat. 
                                   H.*: Hsarat. 
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3.1.3 Column chromatography of the crude oil 
A column chromatography of the crude oil of closed umbels collected from various 
locations (with an average of 35%) was performed in order to separate the different 
components of the crude oil. Four fractions were obtained and then subjected to thin layer 
chromatography. Figure 3 shows a schematic representation of the compound distributions 
on the TLC. β-2-himachalen-6-ol appeared as a pink spot when stained with anisaldehyde 
and eluted with 7:3 hexane: ethyl acetate. The Rf value was calculated to be 0.70 (figure 
3). A Gas chromatogram of F2, shown in figure 4, revealed that the percentage 
composition of β-2-himachalen-6-ol (Peak at 23.446) is 78.7%. 
 
Figure 3: TLC of F1-F4 fractions in 7:3 hexane: ethyl acetate. Major compound shown 
having an Rf = 0.7. 
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Figure 4: Gas chromatogram of F2.  
3.1.4 Column chromatography of the major compound 
A column chromatography of the F2 fraction was then performed to purify β-2-
himachalen-6-ol. Figure 5 shows a schematic representation of the compound distributions 
on the TLC of the various F2. 
 
Figure 5: TLC of F2 sub-fractions using 7:3 hexane: ethyl acetate as the mobile phase. 
Major compound shown having an Rf = 0.7. 
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Figure 6: Gas chromatogram of F2.1. 
Since F2.1 showed the highest relative concentration of β-2-himachalen-6-ol, a 
third column chromatography was performed for further purification. It appeared that 
F2.1.4 has the highest percentage composition with purity of 96%. Figure 8 shows the MS 
data of the pure compound β-2-himachalen-6-ol with a MW of 222.2. Further NMR 
studies in our laboratory confirmed it to be β-2-himachalen-6-ol. 
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Figure 7: Gas chromatogram of F2.1.4 (β-2-himachalen-6-ol). 
 
 
Figure 8: MS of β-2-himachalen-6-ol. 
3.2 Cytotoxicity of β-2-himachalen-6-ol 
The cytotoxicity of β-2-himachalen-6-ol was tested on a panel of four AML cell 
lines. All the AML cell lines were susceptible to β-2-himachalen-6-ol treatment with an 
IC50 ranging between 12 and 30 µg/mL at 48 hours post-treatment. In order to eliminate 
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any role of DMSO, the solvent used to dissolve the major compound in the cytotoxicity 
assay, control groups were treated with DMSO at the same volume of the major 
compound. DMSO has no effect except at the volume corresponding to 1000 µg/mL. 
Hence, the cytotoxicity seen in AML cell lines is due to β-2-himachalen-6-ol. 
    
        
                                                       
Figure 9: non-linear regression of the cytotoxicity assay of β-2-himachalen-6-ol and 
DMSO against five AML cell lines: HL60, ML2, KG1, Mono-Mac-I, and U937. 
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3.3 Influence of β-2-himachalen-6-ol on the cell cycle 
The cell cycle status of four different AML cell lines (ML2, U937, Mono-Mac-I, 
and HL60) was determined 48 hours post treatment with four different concentrations (0, 
0.45, 37.04, and 1000 µg/mL) in order to verify if β-2-himachalen-6-ol induces cell cycle 
arrest in human AML cell lines. A decrease in the fraction of cells in G0/G1 and G2/M 
phases was observed as the concentration of β-2-himachalen-6-ol has increased in HL60 
and ML2. This decrease was associated with an elevation in the fraction of cells in the 
sub-G1 phase in a dose dependent manner. Consequently, treatment of ML2 and HL60 
with β-2-himachalen-6-ol induces cell death. Treatment of Mono-Mac-1 and U937 with a 
low concentration of β-2-himachalen-6-ol revealed an accumulation of cells in the G0/G1 
phase, thus β-2-himachalen-6-ol induces cell cycle arrest in Mono-Mac-1 and U937 at low 
concentration (0.45 µg/mL). However, Treatment of Mono-Mac-1 and U937 with a high 
concentration of β-2-himachalen-6-ol revealed an accumulation of cells in sub-G1 phase, 
hence, β-2-himachalen-6-ol induces cell death in Mono-Mac-1 and U937 at mid and high 
concentrations (37.04 and 1000 µg/mL). 
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D) 
   
                                                                  
Figure 10: Cell cycle analysis of HL60 (A), ML2 (B), Mono-Mac-1 (C), and U937 (D) 
after treatment with different concentrations of β-2-himachalen-6-ol for 48 hours. Cells 
are gated on width versus forward scatter (R1). Cells in G0/G1 are gated M1, G2/M are 
gated M2 and pre-G0/G1 (dead) are gated M4. 
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3.4 Analysis of cell death 
In order to verify the kind of cell death after treating AML cell lines with β-2-
himachalen-6-ol, annexin V/PI staining and caspase activation were tested on panel of 
four AML cell lines (HL60, ML2, Mono-Mac-1, and U937) after 48 hours treatment with 
four different concentrations (control, 0.45 µg/mL, 37.04 µg/mL, and 1000 µg/mL). 
Generally, cells which are negative for both annexin V and PI staining are living cells. 
Cells which are positive for annexin V, negative for PI, and positive for active caspase 
staining are early apoptotic cells. Cells which are negative for annexin V, positive for PI, 
and negative for active caspase are necrotic cells. Cells which are positive for both annexin 
V and PI staining can be either late apoptotic or necrotic cells. These cells if they stain 
positively for active caspase they are late apoptotic, however, if they stain negatively for 
active caspase, they are necrotic. Our data revealed that all AML cell lines showed a dose-
dependent elevation in the percentage of cells which are positive for both annexin V and 
PI staining. Staining for active caspase in cells treated with β-2-himachalen-6-ol showed 
a dose-dependent elevation in caspase activation. Thus, the elevation in the percentage of 
cells which are positive for annexin V, and PI staining, and which are also staining 
positively for caspase activation revealed that β-2-himachalen-6-ol  promotes caspase-
dependent , apoptotic cell death in the panel of AML cells.  
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B)  
 
 
Figure 11:  Analysis of cell death of HL60, ML2, Mono-Mac-1, and U937 after treatment 
with different concentrations of β-2-himachalen-6-ol  for 48 hours using Annexin V/PI 
staining (A), and active caspase staining (B).  
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3.5 Effect of MAPK pathway inhibition 
In order to determine the effect of the inhibition of the MAPK pathway in AML 
cell lines on β-2-himachalen-6-ol, the cytotoxicity of the compound was tested on a panel 
of AML cell line with two different concentrations of U0126 (20 µM and 50 µM) which 
is  a MEK1/MEK2 inhibitor. Also, AML cell lines were also co-incubated with 50 µg/mL 
of β-2-himachalen-6-ol and U0126 at 20 µM and 50 µM. Results showed that Co- 
incubation of AML cell lines with U0126 showed additive effect in Mono-Mac 1 and 
U937 cell lines, but very mild effect was observed in HL60 cells. In Mono-Mac-1 and 
HL60 cells inhibiting the MAPK pathway increased the effect of β-2-himachalen-6-ol, 
indicating that another mechanism complementary to β-2-himachalen-6-ol may be 
involved.  
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Figure 12: The effect of β-2-himachalen-6-ol on Mono-Mac-1 (A), U937 (B), and HL60 
(C) in the presence and absence of U0126. 
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CHAPTER 4 
DISCUSSION 
Chemotherapeutic treatments based on herbal medicine revealed promising results 
in treating various types of cancers, since phytochemicals either inhibits cell proliferation 
or induces apoptosis (Ouhtit et al., 2013; Sak, 2014; Shebaby et al., 2015a; Zeinab et al., 
2011). Recent works in our lab showed that DCOE oil extract and its fractions possess 
potent anticancer activity against various type of cancer cells including breast, colon, and 
leukemia (Shebaby et al., 2015a; Shebaby et al., 2014; Shebaby et al., 2013; Tawil et al., 
2014). We have also shown that the composition of DCOE varied drastically with 
geographical locations between Lebanon and other European countries (Shebaby et al., 
2013). In the current study, we have demonstrated that the composition of the Lebanese 
DCOE varies drastically when the plant is collected from two different locations that are 
even less than 30 kilometers away. In addition, there was a significant variation in the 
chemical composition of the various plant parts. Recently, Shebaby at al. (2015a) has 
shown that F2 fraction containing β-2-himachalen-6-ol as a major compound has a very 
potent anticancer activity. In the present study, β-2-himachalen-6-ol exhibited the highest 
percentage composition in closed umbels. Altitude did not affect the content of this major 
compound once the umbel is closed. However, there was more variation when the umbel 
is open. In the present work, we have isolated β-2-himachalen-6-ol and tested its cytotoxic 
effect on a panel of AML cells. 
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DCOE obtained from umbels is rich in sesquiterpenes such as β-2-himachalen-6-
ol, β-bisabolene, β-selinene, α-longipinene, humulene, α-Selinene, β-himachalene, and 
caryophyllene. β-2-himachalen-6-ol is more concentrated in the umbels collected from 
Mounsif than the one collected from Amioun. The extract is also rich in phenylpropanoids 
such as elemicin, and terpenes such as D-limonene. These sesquiterpenes, 
phenylpropanoids and terpenes are absent in stems, roots and leaves. These secondary 
metabolites were reported to possess antioxidant and anticancer activities in various 
studies (Silva et al., 2011). Some of the phytochemicals found in the DCOE obtained from 
various plant organs were reported to possess biological activities as follow:  
Table 6: Biological activities of certain phytochemicals found in the oil extracted from 
the various Daucus carota parts. 
Phytocomponent  Biological activities 
Hexadecanoic acid, methyl ester Anti-inflammatory, anti-fungal, anti-androgenic flavor, pesticide, 
haemolytic, anti-microbial, 5-Alpha reductase inhibitor, and it 
reduces blood cholesterol (Hema, Kumaravel, & Alagusundaram, 
2011). 
 
Linolenic acid, methyl ester 
 
Hyperchloesteralemic, antioxidant, antimicrobial, and anticancer 
(Kumar, Kumaravel, & Lalitha, 2010). 
 
Linoleic acid, methyl ester 
 
Hepatoprotective, 5- Alpha reductase inhibitor, insectifuge, 
nematicide, anticoronary, antiarthritic, antiandrogenic, antiacne, 
antieczemic, antihistaminic, anti-inflammatory, and 
hypocholesterolemic cancer (Roy, Amdekar, Kumar, & Singh, 
2011). 
 
Eicosane 
 
Antitumor, antibacterial, antifungal, and cytotoxic (Hsouna et al., 
2011). 
 
β-sitosterol 
 
Antioxidant, reduces the level of LDL-cholesterol in blood and 
cardiovascular diseases, and prevents tumor growth (Grattan, 
2013). 
 
Stigmasterol 
 
Antiviral, anti-inflammatory, antihepatotoxic, anticancer, and 
anesthetic (Duke, 2002). 
 
Terpinolene  
 
Antioxidant and anticancer (Aydin, Türkez, & Taşdemir, 2013). 
 
Dodecyl acrylate 
 
Antimicrobial and antioxidant (Ismail, Abdullah, & CHONG, 
2014). 
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This study revealed that some of the phytochemicals present in Amioun are absent in 
Mounsif or vice versa. This variation may be attributed to the soil nature which may differ 
from one region to another. However, there are no enough data to confirm this hypothesis. 
As expected, the geographical distribution of Daucus carota influences its composition.  
The present work shows clearly that β-2-himachalen-6-ol reaches its maximal 
concentration as the flower matures and becomes a closed umbel. The concentration of β-
2-himachalen-6-ol in open and closed Daucus carota umbels collected from three 
different altitudes in Mount Lebanon was also studied. As shown in table 3, the percentage 
composition of β-2-himachalen-6-ol in open umbels decreases drastically with increase in 
altitude (43.06% at sea level; 7.31% at 200 m; 0% at 500 m). However, the relative 
concentrations of β-2-himachalen-6-ol in the closed umbel were similar at different 
altitudes (77.36 at sea level, 76.59% at 200 m, and 80.47% at 500 m). The high percentage 
of β-2-himachalen-6-ol observed at sea level in the open umbel may be due to 
environmental factors such as the prevalent warm weather. Under such condition the 
mature umbel will close earlier than at higher altitude and this is a turning point where β-
2-himachalen-6-ol concentration starts increasing until it reaches its maximal 
concentration when the umbel is completely closed. Such conclusion is supported by the 
fact that similar percentages of β-2-himachalen-6-ol were observed in closed umbels (after 
being much lower in open umbels) collected from the three different altitudes. As a 
conclusion, in order to increase the efficiency of β-2-himachalen-6-ol extraction from 
DCOE, one should originally collect only closed umbels grown in Mount Lebanon region. 
Wild carrot is one of the plants used in Lebanese folk medicine for the treatment 
of various ailments including cancer. However, until recent work in our laboratory, there 
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was no scientific evidence of its anticancer activity.  The oil extracted from the Daucus 
carota umbels and its fractions was shown to possess potent anti-inflammatory, anticancer 
and antioxidant activities (Shebaby et al., 2014; Shebaby et al., 2013; Wehbe, Mroueh, & 
Daher, 2009). The anticancer activity was suggested to be correlated to the major 
compound β-2-himachalen-6-ol present in the F2 (Pentane/Diethyl ether) fraction. 
Therefore, in the current study, β-2-himachalen-6-ol was isolated from the crude extract 
and tested for its anticancer activity against a panel of acute myeloid leukemia cells. 
Fractionation of F2, the most potent fraction (Shebaby et al., 2015a; Shebaby et al., 2014), 
was carried out yielding β-2-himachalen-6-ol with 96% purity.  To the best of our 
knowledge, no such work was previously conducted on this compound. However, an 
isomer of β 2-himachalene-6-ol, widdrol, isolated from Juniperus chinensis, inhibited 
proliferation and induced G1 cell cycle arrest in colon adenocarcinoma cell line (HT-29) 
(Kwon, Lee, Hong, Yun, & Kim, 2010).  
Many phytochemicals, as vinblastine, vincristine, etoposide, bruceantin, and 
silvestrol were used to treat cancers of lymphoid and hematopoietic tissues (Alachkar et 
al., 2013; Bates, Danilov, Lowrey, & Eastman, 2013; Cuendet et al., 2004; Trifilio et al., 
2013; Watanabe et al., 2013). However, the number of phytochemicals used in treatment 
of AML is relatively small. Thus, novel therapies using new phytochemicals are intensely 
required to treat AML. In the present study, we investigated the effect of β-2-himachalen-
6-ol on a panel of five AML cell lines and showed a strong cytotoxicity against the tested 
cells. Such an effect was similar to that observed recently in our lab when β-2-himachalen-
6-ol was tested against SF-268, B16F-10, MB-MDA-231, and Caco-2 cancer cells (Taleb 
et al. 2015, submitted). Moreover, it was previously demonstrated that the oil extract has 
no significant effect against normal blasts from human peripheral blood mononuclear cell. 
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As a result the oil extract, containing β-2-himachalen-6-ol as a major compound, has a 
selective anti-proliferative effect against AML cancer cells (Tawil et al., 2014). In the 
present study, data show that β-2-himachalen-6-ol exhibits potent cytotoxicity on all AML 
cancer cells used. The highest cytotoxicity was observed with Mono-Mac-1 (IC50=12 
µg/ml) while the lowest was with U937 (IC50=30 µg/ml).  In order to understand the 
mechanism of action, the cell cycle and apoptotic paths were targeted in HL-60, Mono-
Mac-1, ML2 and U937 cells treated with β-2-himachalen-6-ol. Flow cytometry analyses 
have shown that cells accumulated in the sub-G1 phase which is an apoptotic phase. 
Generally, cells which are negative for both annexin V and PI staining are living cells. 
Cells which are positive for annexin V, negative for PI, and positive for active caspase 
staining are early apoptotic cells. Cells which are negative for annexin V, positive for PI, 
and negative for active caspase are necrotic cells. Cells which are positive for both annexin 
V and PI staining can be either late apoptotic or necrotic cells. These cells if they stain 
positively for active caspase they are late apoptotic, however, if they stain negatively for 
active caspase, they are necrotic. Our cells are positive for annexin V, PI staining and 
caspase, thus, they are considered late apoptotic cells. The cell membrane may have lost 
its integrity due to the long incubation period with the drug. Probably, incubation for 24 
hours reveals positive staining only for Annexin V and active caspase. Moreover, AML 
cell lines are staining positive for caspase activation confirming that β-2-himachalen-6-ol 
promotes caspase-dependent apoptotic cell death in the panel of AML cells.  These results 
are in accordance with the findings obtained by testing DCOE on AML cell lines (Tawil 
et al., 2014).  
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The MAPK/ERK pathway participates in the regulation of cell survival, 
proliferation, and apoptosis. Elevated levels of active ERK are associated with growth in 
several cancers (A. Dhillon, Hagan, Rath, & Kolch, 2007; Yang, Sharrocks, & Whitmarsh, 
2013). On the contrary, down-regulating the activity of ERK results in the inhibition of 
proliferation, metastasis, and angiogenesis in cancer cells (Kohno & Pouyssegur, 2006). 
Previous findings showed that most of the AML cancer cells become sensitive to treatment 
upon inhibiting the MAPK pathway (Kassab et al., 2013). Thus, some molecular pathways 
causing the cytotoxicity of β-2-himachalen-6-ol against AML cell lines were investigated 
by studying the effects of combining β-2-himachalen-6-ol and U0126 which is a small 
molecular weight MEK1/2 inhibitor. Results revealed that the tested AML cell lines were 
sensitive to the inhibition of the MAPK pathway by U0126, and combining both β-2-
himachalen-6-ol and U0126 showed additive effect in Mono-Mac 1 and U937 cell lines, 
but very mild effect was observed in HL60 cells. Recent works in our lab have revealed 
the that DCOE F2 fraction inhibits cell proliferation by inducing cell cycle arrest and 
apoptosis in HT-29 cells through the suppression of MAPK/Erk and PI3K/Akt pathways 
(Shebaby et al., 2015a). Therefore, the cytotoxicity of β-2-himachalen-6-ol to AML cancer 
cells may rely on the inhibition of these 2 pathways. However, further investigation will 
be performed to study the pathways responsible for the robust cytotoxicity of β-2-
himachalen-6-ol against AML cell lines using western blot techniques.  
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CHAPTER 5 
CONCLUSION 
In conclusion, β-2-himachalen-6-ol seems to be unique to the Lebanese wild carrot 
and it appeared to be maximally abundant in plant confined to Mount Lebanon. The 
chemical composition of Daucus carota seems to vary significantly according to 
geographical location and plant parts. β-2-himachalen-6-ol appeared to be present only in 
the plant umbel and it is at its maximum concentration when the umbel is closed. Altitude 
did not affect the content of this major compound once the umbel is closed. The present 
study also revealed that β-2-himachalen-6-ol exhibited high cytotoxicity against a panel 
of AML cell lines. This effect is mediated through a caspase-dependent apoptotic cell 
death which could be attributed to suppression of MAPK/Erk and PI3K/Akt pathways. 
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APPENDICES 
Appendix A: Daucus carota oil extract percent composition in roots, stems, 
leaves and   umbels collected from Amioun and Mounsif area. Components of > 0.5% 
are listed below. 
Component Rt* Root Stem Leaf Umbel 
  A* M* A* M* A* M* A* M* 
Benzene, tert-butyl- 4.945 - - - - - 38.69 - 6.62 
Unidentified A 4.951 - 4.42 - 4.93 - - - - 
D-Limonene 5.534 - - - - - - - 1.32 
Unidentified B 6.054 - 0.66 - - - - - - 
Terpinolene 6.608 0.79 - - - - - - - 
Unidentified C 6.746 - 1 - - - - - - 
Unidentified D 6.752 - - - 3.44 - 6.94 - - 
Unidentified E 8.821 - 0.59 - - - - - - 
Unidentified F 9.112 - 0.64 - - - - - - 
Unidentified G 9.444 - 0.54 - - - - - - 
Unidentified H 9.454 1.71 - - - - - - - 
α-longipinene 11.712 - - - - - - - 8.58 
Caryophyllene 13.735 - - - - - - 1.54 - 
Unidentified I 14.702 - 1.65 - - - - - - 
1,4,7,-Cycloundecatriene, 1,5,9,9- tetramethyl-, Z,Z,Z- 14.942 - 2.69 - - - - 1.33 - 
Humulene 14.953 - - - - - - - 6.89 
Unidentified J 15.205 - 2.27 - - - - - - 
Germacrene D 16.010 4.17 16.73 1.11 - - 5.59 2.39 - 
 β-Selinene 16.221 - - - - - - 9.26 2.94 
Unidentified K 16.325 - 11.18 - - - - - - 
Unidentified L 16.481 - - 1.52 - - - - - 
Unidentified M 16.484 1.54 - - - - - 1.39 - 
α-Selinene 16.575 - - - - - - 3.57 - 
Unidentified N 16.577 - 6.39 - - - - - - 
β-Himachalene 16.799 - - - - - - - 2.79 
β-Bisabolene 17.096 - - - - - - 5.84 12.72 
Shyobunone 17.330 6.27 - 4.05 - 8.47 - 3.30 - 
Elemicin 19.193 - - - - - - 12.46 8.48 
Unidentified O 19.881 - - - 10.56 - - - - 
Unidentified P 21.325 2.68 - - - - - 4.06 - 
Unidentified Q 21.326 - - - - 5.50 - - - 
Unidentified R 21.327 - - 1.90 - - - - - 
Unidentified S 22.765 - - - - - - 3.35 - 
β-2-himachalen-6-ol 23.063 - - - - - - - 49.67 
Dodecyl acrylate 25.600 5.48 - - - - - - - 
2-Propenoic acid, oxybis(methyl-2,1-ethanediyl) ester 25.612 - - - - 6.92 - - - 
2-Propenoic acid, tridecyl ester 25.614 - - 2.05 - - - - - 
Palmitic acid, methyl ester 36.808 4.11 0.90 5.27 - - - 5.41 - 
Linoleic acid, methyl ester 45.411 8.10 1.61 6.59 - - - - - 
11,14-Octadecadienoic acid, methyl ester 45.421 - - - - - - 7.98 - 
Linolenic acid, methyl ester 45.824 - - 8.50 - - - 7.52 - 
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Unidentified T 47.690 5.40 - - - - - - - 
Unidentified U 50.391 - - 1.83 - - - - - 
Unidentified V 51.584 - - - 5.22 - - - - 
Unidentified W 51.591 - - 2.25 - - - - - 
Unidentified X 52.402 - - 0.73 - - - - - 
Unidentified Y 53.607 - 2.16 - - - - - - 
Unidentified Z 55.317 - - 1.01 - - - - - 
Phenol, 2,2'-methylenebis[6-(1,1-dimethylethyl)-4-
methyl- 
56.152 1.45 - 0.51 14.13 8.06 - - - 
Unidentified AA 57.035 - - - - - - 8.13 - 
Unidentified AB 57.036 -  - - 9.39 - - - 
Unidentified AC 57.042 - - - - - 19.17 - - 
Unidentified AD 57.054 - 2.32 - 10.78 - - - - 
Unidentified AE 57.055 - - 6.70 - - - - - 
13-Docosenoic acid, methyl ester 57.167 - - - - 9.14 - 6.75 - 
Unidentified AF 57.174 0.84 2.25 5.19 - - - - - 
Unidentified AG 57.179 - - - - - 22.11 - - 
Unidentified AH 57.180 - - - 9.07 - - - - 
Unidentified AI 57.255 - - 13.54 - - - - - 
Unidentified AJ 57.300 - - - 5.23 - - - - 
Unidentified AK 57.311 - 3.15 - - - - - - 
Unidentified AL 57.315 - - - - - - 1.52 - 
Unidentified AM 57.585 - 8.07 - 6.79 - - - - 
Unidentified AN 57.595 2.29 - - - - - - - 
Unidentified AO 57.602 - - - - - 4.26 - - 
Unidentified AP 57.614 - - - 5.40 - - - - 
Unidentified AQ 57.636 - - - - - 3.24 - - 
Unidentified AR 57.638 - - 7.54 - - - - - 
Unidentified AS 57.642 - 17.57 - - - - - - 
Unidentified AT 57.647 17.36 - - - - - 2.72 - 
Unidentified AU 57.666 - - - 13.46 - - - - 
Unidentified AV 57.678 - - 4.47 - - - - - 
Unidentified AW 57.744 - - - - - - 1.49 - 
Unidentified AX 57.775 - - 15.86 7.92 - - - - 
Unidentified AY 58.031 - 1.18 - - - - - - 
13-Docosenamide, (Z)- 59.505 28.77 7.06 - - - - 10.02 - 
Oleamide 59.507 - - 6.87 - 52.53 - - - 
Unidentified AZ 59.523 - - - 3.08 - - - - 
Unidentified BA 59.956 1.18 - - - - - - - 
Eicosane 60.610 - - 1.27 - - - - - 
Stigmasterol 66.044 - 0.71 - - - - - - 
β-Sitosterol 67.256 7.86 2.35 1.21 - - - - - 
 
Rt*: Retention time.  
A*: Amioun.  
M*: Mounsif 
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